Methodological limitations in the diagnostic validation of P-C4BP-Rf for ovarian clear cell carcinoma versus endometrioma: addressing sample size constraints and selective bias
letter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper identifies methodological limitations, specifically sample size constraints and selective bias, in the diagnostic validation of P-C4BP-Rf for ovarian clear cell carcinoma versus endometrioma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (7)
- Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma via openalex
- W3155414971 via openalex
- doi:10.1007/s13312-011-0055-4 via openalex
- doi:10.1016/j.jclinepi.2014.02.008 via openalex
- doi:10.4143/crt.2014.324 via openalex
- doi:10.3390/cancers12123730 via openalex
- doi:10.1002/sim.7993 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:53:11.423351+00:00
- unpaywall
- last seen: 2026-09-26T06:30:31.687879+00:00
License: CC0
· commercial use OK